Brenda Thompson: Daily
Insightful analysis on the breakthroughs, brands, and business models of tomorrow.
BT
Editor
Brenda Thompson
About This Column
Brenda Thompson is a commentator and strategist exploring the intersection of technical understanding and global strategy. Transitioning from her deep dive into specialized industrial crossroads, Brenda now delivers daily dispatches on the broad trends defining the 2026 landscape - from the evolution of the "longevity economy" to the future of digital experience. With a reputation for providing nuanced analysis of "how changes improve lives," she offers a unique lens on the strategies that drive lasting value. Her writing is essential reading for anyone seeking to stay ahead of the curve in a rapidly changing world.
Displaying items 781-800 of 871 in total
Read full article
GlycoNex Deal Ignites Hope for First-in-Class Dementia Therapy
Read full article
Redefining Antibiotic Delivery: Inside B. Braun's New Safety System
Read full article
Parexel's Power Play: Decoding its Hematology Leadership at ASH 2025
Read full article
Speke AI's Playbook to Free Clinicians from Digital Paperwork
Read full article
Enlivex's Crypto Gambit: A Biotech's Bold Bet on Digital Assets
Read full article
The Data Dividend: How Hospitals Achieved a Patient Safety Revolution
Read full article
Nona Bio Bets on AI Chief to Win Drug Discovery's High-Stakes Race
Read full article
Curi Bio’s $10M Boost: A Bet on Human Models to Fix Drug Discovery
Read full article
Menopause at Work: The Hidden Metabolic Cost Employers Can't Ignore
Read full article
AI Digital Twins: Fixing Pharma’s Billion-Dollar Bottleneck
Read full article
Evestia's Power Play: Building a 'Dream Team' for CRO Dominance
Read full article
Adicet's Strategic Hire: A Signal in Biotech's Fierce Talent War
Read full article
China's Biotech Milestone: Fucaso Approval Signals a New Global Era
Read full article
The Micro-Needle Revolution: How Tiny Silicon Spikes Are Going Global
Read full article
Moleculin's High-Stakes Pitch: Cancer Breakthroughs vs. Cash Burn
Read full article
Otsuka's VOYXACT: A New Dawn in the Fight Against IgA Nephropathy
Read full article
China's Paper Giant Pivots to Green Packaging with Record-Breaking Tech
Read full article
MiCare Path's Dual Leap: Funding & Acquisition Reshape Virtual Care
Read full article
Aidoc's AI Leap: Foundation Model Aims to Triage a Dozen Conditions
Read full article
UCID: 32
